Object. Surgical interventions for medically refractory epilepsy are effective in selected patients, but they are underutilized. There remains a lack of pooled data on complication rates and their changes over a period of multiple decades. The authors performed a systematic review and meta-analysis of reported complications from intracranial epilepsy surgery from 1980 to 2012.
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P atients with poorly controlled seizures have a much higher susceptibility to accident, injury, and death compared with patients whose seizures are well controlled. 5, 8, 82, 90 Uncontrolled seizures are also associated with an elevated risk for sudden unexpected death in epilepsy (SUDEP). 32, 59, 75 Pharmacological approaches to reducing seizure frequency, while effective in many cases, are dependent on continued drug compliance through out the course of a person's life. Additionally, in approximately 30%-40% of patients, the epilepsy is pharmacoresistant. 32 For these medically refractory patients, surgical interventions are a viable, though invasive, alternative to drug therapy and may dramatically reduce the frequency of seizures and significantly improve quality of life. 71, 73, 81, 94 In 2009, Schmidt and Stavem compared long-term seizure outcome of drug-resistant patients who underwent surgery and medical treatment to the long-term seizure outcome of patients treated with antiepileptic drugs (AEDs) alone. 62 They found that patients who underwent surgical intervention were 4 times more likely to achieve seizure control. In a randomized controlled study by Wiebe et al., the authors found that 58% of patients who underwent surgery for the treatment of temporal lobe epilepsy were seizure free, while only 8% of medically treated patients achieved similar results. 85 Despite the curative potential of surgical interventions, there exists a disparity between the number of patients reEvolution of cranial epilepsy surgery complication rates: a 32-year systematic review and meta-analysis ferred for epilepsy surgery and the number of potentially suitable surgical candidates. 20 In fact, epilepsy surgery utilization has been steadily decreasing in the United States over the last few years. 26 Since the risks of persistent medical intractability must be weighed against the risks of surgery, one possible explanation for underutilization could be a lack of clear understanding of the actual risks of epilepsy surgery. Such a knowledge gap could influence referrals in two ways. Epileptologists might believe that the risks of surgery are higher than they actually are and not refer patients to avoid complications. Alternatively, epileptologists might believe that the risks are lower than they actually are and become wary when the inevitable complications occur, thereby hindering further referrals. Additionally, as surgical technique improves and risks decrease, epileptologists may make decisions based on earlier time periods when complication rates were higher than in the modern neurosurgical era.
To facilitate decision making and a dialogue based on reported facts and not anecdotal experience, we embarked on a comprehensive literature review and metaanalysis of the complications of epilepsy surgery. Since there are currently no clear guidelines as to when to undertake implantation of electrodes (Phase 1 and 2 data are discordant), and since the risks of the 2 operations are additive, we evaluate in the current study the risks of electrode implantation independently from those of resective surgery to clarify the additional risk entailed with the decision to implant electrodes or move directly to surgery.
Methods

Data Collection
Two researchers performed a comprehensive literature search (see Table 1 for search terms and steps) using Google Scholar, PubMed, and OvidSP to identify full-length original peer-reviewed articles published in English between 1980 and 2012 that contained at least 2 patients of any age undergoing resective epilepsy surgery and/or invasive electrode placement. Bibliographies of reviews and original articles were also searched. Any areas of potential conflict or disagreement were identified and resolved collectively. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed throughout.
Data Selection and Classification
The following criteria for study inclusion was applied: 1) reports of at least 2 patients of any age undergoing resective or nonresective epilepsy surgery, 2) a description of the type of surgery and number of patients undergoing each intervention, and 3) a quantitative report of perioperative and/or postoperative complications. Studies with overlapping patient data, case reports, and technical notes were excluded. Additionally, studies that did not report complications-related data, reported only an aggregate complication rate, or discussed complications in a purely qualitative manner were also excluded.
Studies were broken down into 2 main groups based on publication year, 1980-1995 and 1996-2012 , and then further categorized by type of surgical intervention into 1 of 3 groups (Table 2) : Group A contained temporal resections with or without amygdalohippocampectomy; Group B, extratemporal/multilobar resections; and Group C, subdural and depth electrode implantation for invasive electroencephalography. Every effort was made to differentiate the complication associated with electrode implantation alone compared with a combined implant/ resection complication rate. In cases in which this determination could not be made, cases were excluded so as not to contaminate the data.
Complications-related data were based on the longest follow-up period provided. Deaths within 30 days of surgery were designated as operative complications. Changes in postoperative neurological/neuropsychological testing that were not specifically reported as a complication were not considered as such for the purposes of this study. Some articles did not specify the duration of postoperative deficits, which would allow for the independent assessment of morbidity. In such cases, these complications were grouped together in a nonspecific "neurological deficits" category. A few articles contained both eligible and ineligible patients. In cases in which the death or deficit could not be confidently associated to an eligible or ineligible patient, complications were allocated proportionally between eligible and ineligible patients.
Data Collection
The author's last name, year of publication, total num ber of patients, number of male and number of female patients (when available), mean age at surgery (when available), number of specific complications by type, and number of deaths were collected from every article and entered into a database.
Statistical Analysis
Meta-analyses for the complication proportions (stratified by the 2 time periods and 3 types of surgery) Step 1:
"Epilepsy surgery" OR "Epilepsy" AND "Surgery" OR "Invasive EEG" OR "Electrode placement" Step 2:
"Complication" OR "Morbidity" OR "Postoperatively developed" Step 3:
Limits: Publication year 1980-2012; Human; Journal article were conducted with the use of StatsDirect statistical software (v 2.7.9). Statistical heterogeneity was tested using a chi-square test (that is, Cochran's Q test), and a p value ≤ 0.20 was used to indicate the presence of heterogeneity. In the case of lacking heterogeneity, fixed-effects models were used for the meta-analyses. If heterogeneity was present (p ≤ 0.20), random-effects models were used for the meta-analyses. For the complication proportions of interest, the results of each study were expressed as binary proportions with 95% confidence intervals. For each meta-analysis of a specific complication type, the presence of publication bias was evaluated through a funnel plot, which is a scatter plot of the complication proportions estimated from individual studies versus a measure of study size or precision. The Begg and Mazumdar rank correlation test was used to statistically assess the presence of publication bias. It tests the null hypothesis of no publication bias by measuring the induced correlation in the funnel plot due to absence of studies in the tail. The cutoff p value was p = 0.05.
Results
Study Selection and Characteristics
Sixty-one articles with a total of 5623 patients met our eligibility criteria ( Fig. 1 ; Tables 3 and 4 ). Of these, 21 (34%) reported on temporal resection, 17 articles (28%) on extratemporal/multilobar resection, and 23 (38%) on intracranial electrode placement. Of the 43 studies in which a mean patient age was available, the weighted mean patient age was 26.45 years, and of the 46 studies (4464 patients) in which gender demographics were available, 47.5% were women and 52.5% were men.
Bias
In the graphic representations (Fig. 2) , larger and more precise studies were plotted at the top of the chart, near the combined (pooled) proportion, whereas smaller and less precise studies showed a wider distribution below. If there was no publication bias, the studies were expected to be symmetrically distributed on both sides of the pooled proportion line. In the case of publication bias, the funnel plot may be asymmetrical because the absence of studies would distort the distribution on the scatter plot.
Operative Complications
For Groups A through C, all identified complications were organized into 10 categories (Table 5) : neurological deficits, wound infections/meningitis, acute seizures, hemorrhage and/or hematoma, pulmonary embolism (PE) or deep vein thrombosis (DVT), CSF-related complications, cerebral vascular accidents (CVAs), hydrocephalus, neuropsychological deficits, and death. Transient, persistent, and unspecified neurological complications were reported together under the neurological deficits category. Persistent neurological complications were also reported separately under persistent neurological deficits. 
Complications of Temporal Resections With and Without Amygdalohippocampectomy (Group A)
Neurological deficits, wound infections/meningitis, hemorrhage and hematoma, CSF complications, CVAs, and psychological complications (including depression and psychosis) were identified from several studies for patients in Group A from 1980 to 2012 (Fig. 3A) . Pulmonary embolism/DVT, hydrocephalus, and miscellaneous complications were exclusively reported in the 1996-2012 time period. There were no deaths in this group.
The most frequent complications encountered during temporal lobectomy in both time periods were neurological complications (19.3%); this was followed by psychological complications (1.3%) and hemorrhage/hematoma (1.2%) ( Table 5 ). The rate of neurological complications decreased over time, from 41.8% in 1980-1995 to 5.2% in 1996-2012. Persistent neurological deficits occurred in 3.8%, decreasing from 9.7% to 0.8% between the 2 time periods. Wound infections/meningitis occurred in 1.4%, decreasing from 2.5% to 1.1%. 
Complications of Extratemporal and/or Multilobar Resections (Group B)
Neurological deficits (hemiparesis, visual field deficits, speech deficits, and so on), wound infections (abscesses, osteomyelitis, osseous defects, wound infections, and so on) and meningitis, hemorrhage and hematoma, CSF complications (CSF leaks, pseudomeningoceles, subgaleal effusions, subdural hygroma, and so on), pulmonary embolisms, and deep vein thrombosis were identified from several studies of patients in Group B from 1980 to 2012 (Fig. 3B) . Acute postoperative seizures were reported as complications in a single study in the 1980-1995 group.
Hydrocephalus and psychological complications were exclusively reported in the 1996-2012 subgroup. Only one death, from the 1980-1995 subgroup, was reported.
The most prevalent complications across both time periods in the extratemporal group were neurological deficits (23.8%), followed by wound infections/meningitis (3.1%) and CSF-related complications (1.6%) ( Table 5 ). The rate of total neurological complications decreased over time from 30.2% in 1980-1995 to 19 .5% in 1996-2012. Persistent neurological deficits occurred in 5.2%, decreasing from 9.0% to 3.2% between the 2 time periods. Wound infections/meningitis occurred in 3.1%, decreasing from 5.3% to 1.9%. The mortality rate was 0.6%. 
Complications of Invasive Electrode Implantation (Group C)
Neurological deficits, wound infections/meningitis, hemorrhage/hematoma, CVA, and device-related complications were reported across both time periods of Group C (Fig. 3C) . Pulmonary embolism/DVT, CSF complications, and death were reported exclusively in the 1996-2012 subgroup.
Neurological deficits (4.3%) and wound infections/ meningitis (3.4%) were the most common, followed by hemorrhage/hematoma/CVA (3.2%) for both time periods. Neurological complications decreased from 6.3% in 1980-1995 to 3.0% in 1996-2012. Persistent neurological defects were uncommon in this group, occurring in 0.5%. Surprisingly, wound infections/meningitis increased from 2.3% to 4.3%, as did hemorrhage/hematoma rising from 1.9% to 4.2%.
Discussion
The Quality Standard Subcommittee of the American Academy of Neurology has recommended that epilepsy surgery be strongly considered for appropriate surgical candidates. Despite the effectiveness of surgical interventions in the treatment of intractable epilepsy, surgery remains underutilized in up to 58% of potential candidates. 20, 26 The reasons behind this inadequate referral of patients are multifactorial. 25 Practitioners may be unclear about the definition of medical intractability, 69 patients may feel that epilepsy surgery is a last-ditch effort that is not a well-established therapy, 80 and neurologists may continue to enroll patients with intractable epilepsy in AED trials. 35 In addition, there may be a lack of understanding among referring doctors regarding the actual risks of epilepsy surgery and how these risks have changed over time. 86 While some neurologists may overestimate the risks, and thus not refer patients for what they perceive is an overly risky procedure, other neurologists may underestimate the risks and become gun shy once the inevitable complications occur. Indeed, transient complications are not uncommon after focal epilepsy surgery, and these can undoubtedly impact early emotional reactions to the surgical procedure. Nevertheless, permanent deficits are quite rare, particularly in more recent years as neurosurgical techniques have evolved. When deciding whether or not to implant electrodes, the incremental knowledge that would be acquired and its influence on potential surgery should be weighed against the increased risks of implantation. Clearly, a full understanding of the risks of epilepsy surgery will facilitate communication and decision making that will help epileptologists and epilepsy surgeons reach an informed consensus regarding the care of each individual patient. Since curative, rather than palliative, surgery has the highest impact on patient improvement, and is the most underutilized, this review has focused on focal epilepsy and focal resections. We reviewed 32 years of epilepsy surgery data to determine not only the risks of surgery but also trends in these risks over time.
Temporal Lobectomy
The first critical finding of this study is that a temporal lobectomy, with or without an amygdalohippocampectomy, has a 0.8% risk of permanent deficits. This risk has dropped by 92% over time. In light of the evidence reported from 2 randomized studies that temporal lobectomy is clearly more effective than medical therapy for the treatment of temporal lobe epilepsy, 24, 85 there is little question that suitable candidates should be referred more frequently for this procedure. Seizure remission rates may be as high as 77% after surgery. 72 As such, novel therapies, including radiosurgery, cell transplantation, and laser ablation, will have to show a comparable risk/ benefit ratio to compete with open surgery.
When implantation of electrodes is required to identify or more fully characterize these patients as suitable surgical candidates, the risks of complications increase substantially. For example, the risk of wound infection is only 1.1% in temporal lobectomy, but if an implant is required the combined risk of infection is 5.8% and the risk of hemorrhage/hematoma grows from 1.2% to 4.3%. Hence, epileptologists who recommend implantation of electrodes for their patients with temporal lobe epilepsy should carefully consider the likelihood that the implant will change the eventual resection and whether a one- stage surgery might not achieve the same results with less risk to the patient.
In general, electrode implants should be reserved for patients in whom data are discordant. Over time the development of more sophisticated noninvasive localizing technology may reduce the need for implantation and the resulting risks of surgery. 15 Nevertheless, infection and hematoma can both be treated without causing permanent neurological deficits, and their morbidity and that of their treatments is relatively trivial compared with the complications and risks associated with a lifetime of intractable epilepsy. 5, 8, 82, 90 Likewise, the risk of permanent neurological deficits with implantation of electrodes is extremely low (0.5%)-much lower than resective surgery. Thus, cases in which the implant has a good chance of turning a patient into a surgical candidate are well worth the increased risk of infection and hematoma as long as the expectations of the epileptologists are in line with the actual risks of temporary neurological deficits and other potential but treatable complications. Additionally, referring physicians should be aware of the small risk of psychiatric complications that occur in the temporal lobe population and, albeit not as commonly, in the extratemporal resections population.
Extratemporal Lobar and Multilobar Resections
Extratemporal epilepsy surgery is known to have a lower rate of seizure remission than temporal lobe resection. 72 The infrequency of radiographically documented abnormalities in this group more often requires electrode implantation to define the seizure onset zone. Referral of patients with presumed extratemporal epilepsy for surgery is, for that reason, frequently hindered by a perceived unfavorable risk/reward relationship. However, a recent multicenter study has shown not only a 56% 1-year remission rate but also a low (4%) rate of relapse following extratemporal resective epilepsy surgery. 72 These results along with our data indicating that permanent neurological deficits after extratemporal epilepsy surgery have decreased in recent years by 64%, from 9.0% to 3.2%, demonstrate a relatively favorable risk/reward ratio. Furthermore, rates of wound infection/meningitis and hemorrhage/hematoma have decreased more substantially for extratemporal surgery than for temporal lobectomy and are now comparable to those of a temporal lobectomy, namely 1.9% and 1.1%, respectively. In contrast to temporal lobectomy, the additional risk of electrode implantation is more justified for extratemporal resections given the more widespread nature of the ictal onset zone, the frequent lack of radiographic evidence of a focal onset zone, and the lower rate of remission.
Electrode Implantation
Perhaps the most surprising finding in the present study was the increased rate of complications over time following electrode implantation. The risk of electrode implantation varies widely in the literature and is often misjudged or misquoted, which further contributes to misunderstanding between neurologists and neurosurgeons. For example, in a chapter written and published in 1998, the risks of electrode implantation are described as "...low (predominantly infections) morbidity (1-2%) are reported after subdural electrode study and these risks are lower in experienced hands." 74 In contrast, 2 papers from experienced centers, published in 2002 and 2011, reported complications (transient and permanent together) ranging from 26% to 48.9%. 14, 31 Reconciling these vastly dichotomous data poses a challenge for epileptologists and epilepsy surgeons in clinical decision making.
Our study confirms that transient complications do indeed occur in a large number of patients, but permanent complications are relatively uncommon. One explanation for rising complication rates could be the increasing use of larger or bilateral arrays and grids, which are associated with higher complication rates, compared with depth electrodes. 31, 84 Another possible explanation could be an increasing sensitivity to complications and more careful documentation over time. However, it is also possible that surgeons are now performing fewer intracranial recordings, resulting in decreased surgical familiarity and increased complication potential. Ultimately, the data reaffirm that clinicians should maximize the extraoperative workup to minimize the size of the implant as much as possible, consider placing depth electrodes if the same question can be answered without a grid, and avoid the use of bilateral grid implants. Once electrode implantation is decided upon, the epileptologist and neurosurgeon should be cognizant of the added risk of the implant in addition to the resection and proceed in a circumspect manner to balance the risks and benefits of each additional electrode array implanted.
Trends Over Time
With only a few small exceptions, the rates of complications have decreased dramatically over time for epilepsy surgery. This trend is common for most surgical procedures as technology such as computer-guided stereotaxy, microdissection technique, and minimally invasive approaches have proliferated and evolved. Likewise, training in epilepsy surgery has become more widespread as comprehensive epilepsy centers proliferate. On the other hand, the rates of adverse events from AED therapy have remained high, even with the development of new medications.
While temporal lobe resection is associated with a low postoperative psychological complication rate (1%-2%), the use of various AEDs has been associated with psychological complications including major depression and psychosis in up to 40% of cases. 3, 4, 50, 63 Adverse effects including memory loss, concentration deficits, and fatigue have each been reported in 40%-50% of patients treated with AEDs, compared with less than 25% of patients who underwent surgery. 6 Despite improved results from surgery and the persistent side effects of AEDs, rates of epilepsy surgery utilization have only decreased. However, the administration of AEDs is continued in most surgical patients, including those who are in postoperative seizure remission.
The rate of neurological complications following temporal lobe resection in the first time period (41.8%) is greater than that of extratemporal resection (30.2%). This relationship becomes the inverse in the later time period, with neurological complications occurring more following extratemporal resection (19.5%) than after temporal resection (5.2%). This change may be due in part to increasingly aggressive extratemporal resections, with temporal resections becoming smaller as surgeons move away from standard temporal lobectomies and toward selective amygdalohippocampectomies.
We can expect that, with further technological advancement and refinement in technique, the risks of epilepsy surgery will continue to decrease, especially at high-volume centers. 27 The size and thickness of subdural grids will decrease, and the ability to transmit electrical signals without tunneling the electrodes through the skin is already forthcoming. 13, 44 There remains a possibility that AEDs will become more safe and effective, and thus continued evaluation of the risk/benefit of medications versus surgery will be required, although at this time the evidence favors surgery in well-selected cases, particularly given the improvements in quality of life for successfully treated patients.
Limitations
The data reported here are limited by the retrospective nature of the study and a current lack of a standardized reporting methodology for patient demographics and operative morbidity. Clear discrepancies exist between the rates of total neurological deficits and the sum of transient neurological deficits and persistent neurological deficits. These discrepancies represent proportions of total neurological deficits that were reported without a clear chronological course and thus may reduce the clinical relevance of the total neurological deficits category.
The inability to assess age-related risk factors and heterogeneity was also a limiting factor. While a very small number of studies reported complications by case, the majority listed the number of complications encountered without attribution to a specific patient. Most studies also reported a wide range of ages. Due to the expansive nature of the present study, efforts to obtain individual patient records from the original authors were not attempted. As a result, no correlations could be made between complication type or frequency and patient sex or age. Additionally, the selected time periods could thus only be based on data publication year and not on actual dates of surgery.
The presence of considerably more patients in the later time group is not, by definition, publication bias, although the presence of fewer patients in the earlier time group could result in reduced complication-reporting accuracy. Although we do not believe this is the case, as the total number of patients is sufficiently representative of the patient population in question, there remains a possibility that the complication proportions in the earlier time period are less accurate than those in the later time period.
Furthermore, the inability to determine an overall complication rate for epilepsy surgery proved to be the greatest limiting factor. This limitation can also be attributed to the inaccessibility of individual patient records and the lack of standard complication reporting. Certain complications were only reported in the later time period, highlighting the discrepancies in reporting methodology and completeness, and although some studies provided total complication rates, most only reported individual complications. As a result, it was unclear whether more than one complication could be attributed to a single patient. This resulted, in some instances, in the total complication rate exceeding 100% and therefore invalidated the possibility of compiling an aggregate complication rate that could accurately demonstrate the likelihood of a single patient developing a postsurgical complication. As such, only the rates of individual complications were calculated.
Conclusions
Complication rates for focal resective epilepsy surgery have decreased dramatically over time. In particular, the risk of permanent neurological deficits is extremely low. Grid implantation carries a higher risk of infection/ meningitis or hemorrhage/hematoma than resection and should be considered only in patients in whom the results will significantly impact eventual resection. The complication rates reported in this article should be carefully considered by both epileptologists and epilepsy surgeons when evaluating patients for epilepsy surgery. 
